Articles |
From the Department of Pharmacology, United Medical and Dental Schools, St Thomas's Hospital, London, UK.
Correspondence to Dr J.C. Kentish, Department of Pharmacology, United Medical and Dental Schools, St Thomas's Hospital, London, SE1 7EH UK.
| Abstract |
|---|
|
|
|---|
Key Words: caffeine CGP 48506 Ca2+ sensitizer crossbridge relaxation rate
| Introduction |
|---|
|
|
|---|
A disadvantage of the Ca2+-sensitizing agents is their tendency to slow the rate of relaxation of the cardiac twitch,4 5 6 7 8 which could compromise diastolic filling of the heart. The decreased relaxation rate could be a consequence of the increase in Ca2+ sensitivity, such that force is produced even at levels of Ca2+ where the muscle is normally relaxed. Alternatively, the twitch relaxation rate may be limited by the intrinsic relaxation rate of the myofibrils, which could be slowed in the presence of a Ca2+ sensitizer.
The aim of the present study was to investigate the effects of CGP 48506 and caffeine on the intrinsic relaxation rate of the myofibrils in skinned cardiac trabeculae. It is possible to achieve a near-instantaneous drop in [Ca2+] using diazo-2, which chelates Ca2+ more strongly after being photolyzed by near-UV light.9 The rate of relaxation of a skinned muscle after photolysis of diazo-2 is then limited by the relaxation properties of the myofibrils rather than by the rate of fall of [Ca2+]. We used diazo-2 to rapidly reduce [Ca2+] around the myofibrils in skinned cardiac muscles and thereby determined whether the Ca2+ sensitizers CGP 48506 and caffeine alter the intrinsic rate of myofibrillar relaxation. Some of these results were published previously in abstract form.10 11
| Materials and Methods |
|---|
|
|
|---|
250 g)
were rendered unconscious with a blow to the head and then were killed
by cervical dislocation. Their hearts were removed, and thin
trabeculae (diameter,
100 to 200 µm; length, 1 to
3 mm) were dissected out from the right ventricle in Tyrode's
solution containing 25 mmol/L 2,3-butanedione monoxime to minimize
cell contracture.14 Each trabecula was then
skinned by a 30-minute immersion in relaxing solution (see below)
containing 1% Triton X-100 and 0.1 mmol/L phenylmethylsulfonyl
fluoride. The ends of the skinned muscle were mounted in nylon
snares attached to a servomotor (300S, Cambridge Technology Inc) and to
an isometric force transducer (AE801, SensoNor; resonant frequency, 3
kHz). The muscle was then lowered into one of a movable series of wells
(each with a volume of 0.5 mL) and was bathed in relaxing solution for
>15 minutes to wash out the detergent. The temperature of the muscle
baths was maintained at 22.0±0.1°C by circulating water from a
thermoregulator. Solutions in the baths were stirred with a jet of
N2. Muscle length was adjusted until resting force was just
detectable; at this length, the sarcomere length in the resting muscle,
measured by diffraction of a HeNe laser beam, was 2.1 µm. For the photolysis experiments, one of the muscle baths was modified to reduce its volume to 10 µL. This bath (like the others) had sides made from pieces of grade-0 glass coverslips. These coverslips absorb light of <310 nm and so help prevent damage to the muscle resulting from very short wavelength light. A xenon flashlamp (Hi-Tech Ltd), containing a UG5 bandpass filter (300 to 400 nm), was focused horizontally onto the bath by using cylindrical and spherical quartz lenses. The size and position of the focused light from the flashlamp were optimized before each experiment by using the burn pattern on light-sensitive paper. By this means, we ensured that the muscle was positioned completely within the region of maximum light intensity during the flash. PClamp software (Axon Instruments) was used to trigger the flashlamp and to record and analyze the resulting force signals, which were recorded on an AT-compatible computer using a 12-bit A/D board (Digidata 1200, Axon) at a sampling rate of 2 kHz. Slow time-base recordings were also made on a four-channel chart recorder.
Solutions
For the skinned muscle experiments using diazo-2, all solutions
contained (mmol/L) BES 100, potassium propionate 50,
Na2H2ATP 6.3, MgCl2 6.4
(Mg2+ 1), Na2 phosphocreatine 10, potassium
phosphate 1, glutathione 5, and leupeptin 0.001 (pH 7.1; ionic
strength, 200 mmol/L). Leupeptin, a protease
inhibitor, reduced the deterioration in force during the
experiments. The above solution (ie, with no added EGTA or
Ca2+) was used as "preactivating solution" (see
below). "Relaxing solution" contained, in addition, 1 mmol/L
EGTA, giving a pCa (-log10[Ca2+]) of 8.5.
"Maximum activation solution" had 1 mmol/L EGTA and 1.1
mmol/L CaCl2 (pCa 4.5). The diazo-2 solutions contained
0.25 mmol/L diazo-2 (added from a stock solution of 20
mmol/L) and 0 to 0.25 mmol/L CaCl2 (final pCa,
7.5
to 4.9). The exact concentration of diazo-2 in the stock solution was
measured from its absorption at 370 nm, assuming an extinction
coefficient of 22 200
(mol/L)-1·cm-1.9
For measurement of force-pCa relationships, the solutions were similar
but contained 10 mmol/L EGTA and 0 to 10.5 mmol/L
Ca2+, with the concentration of potassium propionate
reduced to maintain the ionic strength. Details of the manufacture of
solution and calculation of free ion concentrations have been described
previously.13 The dissociation constants for
Ca2+ and Mg2+ binding to diazo-2 were taken as
2.2 µmol/L and 5.5 mmol/L, respectively, before photolysis and
0.073 µmol/L and 3.4 mmol/L, respectively, after
photolysis.9 Diazo-2 free acid (K+ form) was
obtained from Molecular Probes; CGP 48506 was donated by Ciba-Geigy Ltd
and was prepared as a stock solution of 2 mmol/L in
dimethylsulfoxide (DMSO) because of its limited solubility in aqueous
solution. The final concentration of CGP 48506 in the experimental
solutions was 10 µmol/L (or occasionally 100 µmol/L),
accompanied by 0.5% dimethyl sulfoxide. An equivalent amount of
dimethyl sulfoxide was added to the control solutions and had no effect
on either force or relaxation rate (results not shown). Caffeine was
obtained from Sigma Chemical Co. Other chemicals were obtained from
Sigma or Merck Ltd.
Protocols
At the start of the experiment, the skinned
trabecula was activated several times with maximal
activating solution to check the reproducibility of the force response
and of the resting sarcomere length pattern. These initial activations
consisted of the following sequence of solution changes: relaxing
solution, preactivating solution (used to wash the EGTA out of the
muscle and so minimize its Ca2+-buffering capacity),
maximum activating solution, and relaxing solution. For the part of the
experiment involving diazo-2 photolysis, the procedure was the same,
but the muscle was placed not in activation solution but in a diazo-2
solution in the 10-µL photolysis bath. Fig 1
shows
that, as with activating solution, the Ca2+ in the diazo-2
solution activated the myofibrils and the muscle developed
force. When force was steady, the flashlamp was triggered to deliver a
pulse of near-UV light (
160 mJ in
1 millisecond) to the muscle.
The photolyzed diazo-2 bound some of the free Ca2+ in the
solution and produced a sudden drop in [Ca2+], causing
the muscle to relax rapidly (Fig 1
). The muscle was then returned to
relaxing solution. This was repeated for a range of Ca2+
concentrations in the diazo-2 solution. Control runs (no drug) were
carried out before and after a test run in which either 10
µmol/L CGP 48506 or 20 mmol/L caffeine was present in all
solutions. By varying the initial [Ca2+], it was possible
to check for any dependence of relaxation rate on the preflash
[Ca2+] or force. Frequent application of control maximal
activating solution to the muscle allowed correction for the decline
(assumed linear) in maximum force during an experiment; this amounted
to a decrease of only 21.2±4.9% (mean±SEM, n=6) over 4 to 5 hours.
The force-pCa relationship was determined in the absence and presence
of caffeine or CGP 48506, using six muscles for each (four of which
were common to both drugs). Control and test activating solutions were
applied alternately, in order of increasing [Ca2+], with
relaxation of the fiber between each activation. Flashing the
trabecula in the presence of caffeine or CGP 48506 in these
activation solutions (containing EGTA rather than diazo-2) did not
produce any change in force.
|
Data Analysis
Forces are expressed relative to maximal
Ca2+-activated force under control conditions
unless stated otherwise. The relationship between steady state force
and pCa was fitted by the Hill equation as follows: relative
force=maximum
forcex[Ca2+]nH/(KnH+[Ca2+]nH),
where nH is the Hill coefficient and K is a dissociation
constant. The relaxation of force after diazo-2 photolysis was fitted
to a double-exponential decay using Clampfit software (Axon
Instruments). Values are given as mean±SEM of n experiments. Paired
t tests were applied where appropriate, and a significant
difference was taken as P<.05.
| Results |
|---|
|
|
|---|
|
We used the caged chelator of Ca2+, diazo-2, to investigate
the effects of CGP 48506 and caffeine on the relaxation rate of skinned
trabeculae. Our protocol differs from that in previous
studies16 17 in that we used 0.25 mmol/L diazo-2
rather than 2 mmol/L and flashed the muscles in the bath at 22°C
rather than in air at lower temperatures. We found that a diazo-2
concentration of
1 mmol/L produced only a small relaxation of
Ca2+-activated force using photolysis in the bath,
probably because the high absorbance of diazo-2 resulted in less light
from the flashlamp reaching the muscle itself. However, the relaxation
rates measured in the presence of 0.25 or 0.5 mmol/L diazo-2 were
not significantly different (n=4), indicating that 0.25 mmol/L was
adequate for the present experiments. We also found no difference
between relaxation rates obtained on flashing trabeculae in
air with 0.25 or 2 mmol/L diazo-2 (results not shown).
In the muscle shown in Fig 1
, the diazo-2 after photolysis bound
sufficient Ca2+ to cause complete relaxation of the
trabecula. However, we found that the extent of the
relaxation depended on the initial [Ca2+]. The greatest
drop in force following a flash was achieved when the
trabecula initially produced 70% to 80% of maximum force.
Because of the sigmoidal shape of the force-pCa curve, decreases in
[Ca2+] produced proportionally smaller falls in force as
the level of activation approached maximum. The magnitude of the
decrease in force after photolysis varied between 0% and 75% of
control maximum force (depending on the initial [Ca2+])
and was not altered by either caffeine or CGP 48506 (results not
shown).
Fig 3A
illustrates the effects of caffeine and CGP 48506
on relaxation rate using a faster time scale than that in Fig 1
. The
relaxation of force after diazo-2 photolysis was fitted well by a
double-exponential decay. Since [Ca2+] falls in
1
millisecond, the resulting fall in force reflects the intrinsic
relaxation rate of the myofibrils. It was assumed that the first,
faster decay phase represented the maximum rate of
myofibrillar relaxation (see "Discussion"). Its rate constant was
therefore used to analyze the effects of CGP 48506 and
caffeine on relaxation rate. The origin of the slower phase of
relaxation is unclear (eg, there was no evidence that it was due to
sarcomere rearrangement). In the example shown in Fig 3A
, the initial,
fast rate constant was increased from 16.1 to 31.1
s-1 by caffeine (20 mmol/L) and was
unchanged at 16.0 s-1 by CGP 48506 (10
µmol/L). Thus, caffeine clearly speeded up the rate of relaxation,
whereas CGP 48506 had no effect. A summary of a complete experiment
(Fig 3B
) illustrates that these relaxation rates were
consistent, irrespective of [Ca2+], and also
demonstrates that relaxation rates in control solutions were similar
before and after the addition of the Ca2+ sensitizers. The
data from all the experiments are combined in the Table
.
Caffeine almost doubled the fast rate constant of relaxation from
17.3±2.0 to 30.9±3.7 s-1. On the other hand,
CGP 48506 did not significantly alter the rate (14.4±2.3
s-1 compared with a control value of 16.6±1.7
s-1). Thus, despite their qualitatively
similar effects on the pCa50 of the force-pCa relationship
of skinned cardiac muscles, caffeine and CGP 48506 had different
effects on the rate of relaxation of the myofibrils. In addition,
caffeine (but not CGP 48506) decreased the rate of the slow phase of
relaxation. The amplitudes of the fast or slow exponential phases of
relaxation (see Table
) were not altered by these Ca2+
sensitizers.
|
|
Some experiments were also carried out with 100 µmol/L CGP 48506, which shifted the force-pCa curve leftward by 1.16±0.03 units (n=5, data not shown). CGP 48506 (100 µmol/L) produced a small but significant decrease of the fast rate constant of relaxation from 15.6±0.9 to 12.5±1.4 s-1 (n=5) with no effect on the slow rate constant or the amplitudes of the phases.10 11 However, interpretation of these results was complicated by the possibility that such a high concentration of CGP 48506 may have multiple effects on myofibrillar proteins (see "Discussion").
Since caffeine and CGP 48506 increased the Ca2+ sensitivity
of the myofibrils, Ca2+ activations in the presence of
these drugs either produced higher forces than the control (at the same
[Ca2+]) or were done at lower Ca2+
concentrations (when we tried to match the forces). Therefore, we
checked to see if the drug-induced changes in relaxation rate were due
to the difference in [Ca2+] or force from the control. As
shown in Fig 4
, there was no obvious dependence of
relaxation rate on either preflash [Ca2+] or force,
either under control conditions or in the presence of CGP 48506 (panels
A and B) or caffeine (panels C and D).
|
| Discussion |
|---|
|
|
|---|
17 s-1
at 22°C. This value compares well with the rate of 15.8
s-1 given in a preliminary
report18 using single rat myocytes under very similar
conditions. Other studies have used diazo-2 to investigate relaxation
of skinned cardiac muscle,16 17 but in these, the muscles
were flashed in air. Once in air, the muscle cools down to
12°C
(the dew point), and Pi, from ATP hydrolysis, builds up
within the myoplasm; both changes would by themselves cause some
relaxation of force. To overcome these problems, we photolyzed diazo-2
with the muscle in solution at 22°C. A potential drawback was the
ability of diazo-2 in the solution around the muscle to absorb light of
the wavelengths needed for photolysis of diazo-2 within the muscle. By
using 0.25 mmol/L diazo-2, however, its absorbance was decreased
to an acceptable level. Relaxation rates were not limited by the
diazo-2 concentration, since (1) similar rates were obtained using 0.25
or 0.5 mmol/L diazo-2 (not shown), and (2) caffeine increased
relaxation rate 2-fold by an action on the myofibrils.
In theory, the rate at which force declines after photolysis of diazo-2
could be limited by the rate of Ca2+ release from troponin
C (TnC), by the rate of conformational changes before actomyosin
dissociation, or by the crossbridge detachment rate per se. There are
several lines of evidence indicating that Ca2+ dissociation
from TnC is not the rate-limiting step in relaxation. First, from the
measured affinity of TnC for Ca2+ [KCa,
4x105
(mol/L)-1]12 19 and the apparent
rate constant for Ca2+ binding to TnC
[kon, 1.4x108
(mol/L)-1·s-1],19
the off rate constant
(koff=kon/KCa) should be
350 s-1 (as observed19), which
is much faster than the relaxation rate we measured. Second, if the
relaxation rate was limited by koff, caffeine, which does
not alter the Ca2+ affinity of TnC,12 20
should not affect myofibril relaxation rate. This is clearly not the
case (present results). Third, we previously found the rates of
relaxation were similar after myofibril deactivation caused by
photolysis of diazo-2 or of the photosensitive Ca2+
sensitizer EMD 57033.21 Since EMD 57033 acts directly on
the crossbridges without altering Ca2+ binding to
TnC,22 this similarity in relaxation rates suggests that
the rate is limited by the crossbridges rather than by
koff. Finally, we found that in rat skinned
trabeculae (containing myosin isoform V1), the
rate of relaxation after diazo-2 photolysis was six times faster than
that in guinea pig (myosin V3) trabeculae
(authors' unpublished data, 1996). Since cardiac TnC is highly
conserved between species, these different rates of relaxation were
most likely determined by the myosin moiety. This evidence suggests
that the rate of relaxation is likely to be limited by the rate of
crossbridge detachment. It is possible, however, that the absolute
rates of relaxation we measured were influenced by sarcomere length
changes during relaxation, which would occur because of the compliance
of the muscle ends. Nevertheless, this would not have affected our
conclusions concerning the effects of the drugs on relaxation rate,
since the control and drug were tested on the same muscle.
Drugs that increase the Ca2+ sensitivity of the cardiac myofibrils also tend to prolong the twitch in intact muscle, eg, EMD 57033,7 caffeine,8 and CGP 48506.4 5 6 In the present study, our aim was to test whether Ca2+-sensitizing agents slow the rate of relaxation of the heart through a direct reduction in the intrinsic rate of myofibrillar relaxation. In a previous study, Simnett et al17 (1993) reported that the Ca2+ sensitizer EMD 57033 (10 µmol/L) increased the rate constant for the fast phase of relaxation after diazo-2 photolysis by 37% (from 15.4 to 21.1 s-1) in guinea pig trabeculae in air. However, we recently discovered21 that EMD 57033 is partially destroyed by light of wavelengths similar to those used for diazo-2 photolysis. Since EMD 57033 potentiates force at any given [Ca2+], the flash-induced reduction in EMD 57033 concentration itself causes a decline in tension, the rate of which is similar to that achieved after photolysis of diazo-2 alone.21 Thus, it is difficult to determine the contribution of any effect of EMD 57033 directly on the myofibril relaxation rate when diazo-2 and EMD 57033 are photolyzed concurrently.
We investigated the effects on relaxation rate of two Ca2+
sensitizers, caffeine and CGP 48506, that were not affected by the
flash. It is difficult to explain the observed effects of caffeine and
CGP 48506 on the myofibrils, but clearly, several mechanisms are
involved. The suppression of maximum force by caffeine has been
discussed in detail previously.12 The compounds had
similar effects on the pCa50 of the force-pCa relationship
and might have been expected to have the same mechanism of action. It
is known that neither drug affects Ca2+ binding to
TnC.5 6 12 20 Surprisingly, the two compounds had
different effects on the rate of relaxation after diazo-2 photolysis:
20 mmol/L caffeine increased the rate by 80%, whereas 10
µmol/L CGP 48506 did not alter it. The changes in rate were not a
consequence of the lowered [Ca2+] used in the presence of
a Ca2+ sensitizer (where force was matched to the control
level) or a consequence of the potentiation of preflash force induced
by the Ca2+ sensitizers (when [Ca2+] was kept
at the control level), since relaxation rate was independent of the
initial [Ca2+] or force (Fig 4
). Therefore, caffeine and
CGP 48506 exert their effects on cardiac myofibrils at least partly
through different mechanisms. Since we argue above that relaxation rate
is largely determined by crossbridge kinetics, we suggest that caffeine
increases crossbridge kinetics, although the mechanism of this action
remains unclear. In contrast to the results with caffeine, the
Ca2+ sensitization produced by CGP 48506 occurred without
any significant change in relaxation rate, suggesting no major
alteration in crossbridge kinetics. Since CGP 48506 does not affect the
Ca2+ affinity of TnC,6 the increase in
Ca2+ sensitivity may be due to an action on thin filament
Ca2+ regulation at a step after Ca2+ binding to
TnC. A high concentration (100 µmol/L) of CGP 48506 did slow
relaxation by 20%, which could be due to a slowing of crossbridge
kinetics. The present study focused on a lower (10 µmol/L)
concentration of CGP 48506 to avoid such multiple actions. In addition,
lower concentrations are more likely to be useful therapeutically.
In conclusion, the present results indicate that these
Ca2+-sensitizing agents do not slow the rate of twitch
relaxation through a direct reduction in the intrinsic rate of
myofibrillar relaxation. In fact, we found that caffeine increased the
intrinsic relaxation rate nearly 2-fold. Similarly, Simnett et
al17 (1993) reported that EMD 57033 increased relaxation
rate (although this may have been affected by EMD 57033 photolysis).
With 10 µmol/L CGP 48506, which causes pronounced slowing of the
twitch in intact muscles and cells,4 5 6 there was no change
in the intrinsic rate of myofibrillar relaxation. Thus, it seems likely
that the prolongation of the twitch by Ca2+ sensitizers is
an unavoidable consequence of the enhanced Ca2+
sensitivity, which would cause force to be developed even at the low
concentrations of intracellular Ca2+ found during the later
stages of relaxation. This problem may be exacerbated by certain drugs,
such as EMD 57033, which can cause activation even in the complete
absence of Ca2+,5 23 although caffeine and CGP
48506 do not show this undesirable property. The fact that low
concentrations (
10 µmol/L) of CGP 48506 slow relaxation in
intact cardiac muscles4 5 and cells6 without
slowing the intrinsic rate of myofibrillar relaxation (present
results) suggests that under these conditions the rate of relaxation
during the twitch is limited by the rate of fall of
[Ca2+]i rather than by the kinetic properties
of the myofibrils. A similar conclusion can be made for the slowing of
intact muscle relaxation by caffeine.8
| Acknowledgments |
|---|
| Footnotes |
|---|
Received December 2, 1996; accepted January 14, 1997.
| References |
|---|
|
|
|---|
2.
Butcher RW, Sutherland EW. Adenosine
3',5'-phosphate in biological materials, 1: purification and properties
of cyclic 3',5'-nucleotide phosphodiesterase and use of
this enzyme to characterize adenosine 3',5'-phosphate in human
urine. J Biol Chem. 1962;237:1244-1250.
3. Lues I, Beier N, Jonas R, Klockow M, Haeusler G. The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers. J Cardiovasc Pharmacol. 1993;21:883-892.[Medline] [Order article via Infotrieve]
4. Herold P, Herzig JW, Wenk P, Leutert T, Zbinden P, Fuhrer W, Stutz S, Schenker K, Meier M, Rihs G. 5-Methyl-6-phenyl-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazocine-2,4-dione (BA 41899): representative of a novel class of purely calcium-sensitizing agents. J Med Chem. 1995;38:2946-2954.[Medline] [Order article via Infotrieve]
5.
Palmer S, Di Bello S, Davenport SL, Herzig JW.
The novel inotropic agent CGP 48506 alters force primarily by
Ca2+-independent mechanisms in porcine skinned
trabeculae. Cardiovasc Res. 1996;32:411-421.
6. Wolska BM, Kitada Y, Palmiter KA, Westfall MV, Johnson MD, Solaro RJ. CGP-48506 increases contractility of ventricular myocytes and myofilaments by effects on actin-myosin reaction. Am J Physiol. 1996;39:H24-H32.
7. White J, Lee JA, Shah N, Orchard CH. Differential effects of the optical isomers of EMD 53998 on contraction and cytoplasmic Ca2+ in isolated ferret cardiac muscle. Circ Res. 1993;73:61-70.[Abstract]
8. Allen DG, Kurihara S. Calcium transients in mammalian ventricular muscle. Eur Heart J. 1980;1:(suppl A):5-15.
9. Adams SR, Kao JPY, Tsien RY. Biologically useful chelators that take up Ca2+ upon illumination. J Am Chem Soc. 1989;111:7957-7968.
10. Palmer S, Kentish JC. The effects of caffeine and CGP 48506 on the intrinsic relaxation rate of cardiac myofibrils. J Mol Cell Cardiol. 1996;28:A227. Abstract.
11. Palmer S, Kentish JC. The effects of caffeine and CGP 48506 on the relaxation rate of skinned trabeculae isolated from rat ventricles. J Physiol (Lond). 1996;491:162P. Abstract.
12.
Palmer S, Kentish JC. The role of troponin C in
modulating the Ca2+ sensitivity of mammalian skinned
cardiac and skeletal muscle fibres. J Physiol
(Lond). 1994;480:45-60.
13.
Kentish JC. The effects of inorganic phosphate
and creatine phosphate on force production in skinned muscles
from rat ventricle. J Physiol (Lond). 1986;370:585-604.
14.
Mulieri LA, Hasenfuss G, Ittleman F, Blanchard EM,
Alpert NR. Protection of human left ventricular
myocardium from cutting injury with 2,3-butanedione
monoxime. Circ Res. 1989;65:1441-1444.
15. Wendt IR, Stephenson DG. Effects of caffeine on Ca-activated force production in skinned cardiac and skeletal muscle fibres of the rat. Pflugers Arch. 1983;398:210-216.[Medline] [Order article via Infotrieve]
16.
Zhang R, Zhao J, Mandveno A, Potter JD. Cardiac
troponin I phosphorylation increases the rate of
cardiac muscle relaxation. Circ Res. 1995;76:1028-1035.
17. Simnett SJ, Lipscomb S, Ashley CC, Mulligan IP. The effect of EMD 57033, a novel cardiotonic agent, on the relaxation of skinned cardiac and skeletal muscle produced by photolysis of diazo-2, a caged calcium chelator. Pflugers Arch. 1993;425:175-177.[Medline] [Order article via Infotrieve]
18. Walker JW, Hofmann PA, Lu Z, Moss RL. Rapid relaxation of single cardiac myocytes by photolysis of the Ca2+ chelator diazo-2. Biophys J. 1992;61:A20. Abstract.
19.
Dong WJ, Rosenfeld SS, Wang CK, Gordon AM, Cheung
HC. Kinetic studies of calcium binding to the regulatory site of
troponin C from cardiac muscle. J Biol Chem. 1996;271:688-694.
20. Powers FM, Solaro RJ. Caffeine alters cardiac myofilament activity and regulation independently of Ca2+ binding to troponin C. Am J Physiol. 1995;37:C1348-C1353.
21. Lee JA, Palmer S, Kentish JC. Photolysis of the novel inotropes EMD 57033 and EMD 57439: evidence that Ca2+ sensitization and phosphodiesterase inhibition depend upon the same enantiomeric site. Br J Pharmacol. 1996;118:2037-2044.[Medline] [Order article via Infotrieve]
22.
Solaro RJ, Gambassi G, Warshaw DM, Keller MR, Spurgeon
HA, Beier N, Lakatta EG. Stereoselective actions of
thiadiazinones on canine cardiac myocytes and myofilaments.
Circ Res. 1993;73:981-990.
23. Palmer S, Di Bello S, Herzig JW. The effects of EMD 57033 on rigor tension in porcine skinned cardiac trabecula. Eur J Pharmacol. 1995;294:83-90.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
A. M. Gordon, E. Homsher, and M. Regnier Regulation of Contraction in Striated Muscle Physiol Rev, April 1, 2000; 80(2): 853 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Welikson, S. H. Buck, J. R. Patel, R. L. Moss, K. L. Vikstrom, S. M. Factor, S. Miyata, H. D. Weinberger, and L. A. Leinwand Cardiac myosin heavy chains lacking the light chain binding domain cause hypertrophic cardiomyopathy in mice Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H2148 - H2158. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Simnett, E. C. Johns, S. Lipscomb, I. P. Mulligan, and C. C. Ashley Effect of pH, phosphate, and ADP on relaxation of myocardium after photolysis of diazo 2 Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H951 - H960. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Palmer and J. C. Kentish Roles of Ca2+ and Crossbridge Kinetics in Determining the Maximum Rates of Ca2+ Activation and Relaxation in Rat and Guinea Pig Skinned Trabeculae Circ. Res., July 27, 1998; 83(2): 179 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Endoh Regulation of Myocardial Contractility by a Downstream Mechanism Circ. Res., July 27, 1998; 83(2): 230 - 232. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |